| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1515/CCLM.2001.093 |
| P8608 | Fatcat ID | release_kpsyh6qem5guxay2x3vlwjeyhu |
| P698 | PubMed publication ID | 11522102 |
| P2093 | author name string | J Mair | |
| B Puschendorf | |||
| A Hammerer-Lercher | |||
| P2860 | cites work | Corin, a transmembrane cardiac serine protease, acts as a pro-atrial natriuretic peptide-converting enzyme | Q22254421 |
| Purification and complete amino acid sequence of alpha-human atrial natriuretic polypeptide (alpha-hANP) | Q24301059 | ||
| Structure of the dimerized hormone-binding domain of a guanylyl-cyclase-coupled receptor | Q27625369 | ||
| The natriuretic peptide clearance receptor locally modulates the physiological effects of the natriuretic peptide system | Q28506517 | ||
| Regulation of natriuretic peptide secretion by the heart | Q33547223 | ||
| Hormones and hemodynamics in heart failure | Q33713907 | ||
| Myocardial infarction redefined--a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction | Q33917874 | ||
| Localization of the mosaic transmembrane serine protease corin to heart myocytes | Q33925569 | ||
| Prognostic value of neurohumoral activation in patients with an acute myocardial infarction: effect of captopril | Q34059547 | ||
| A rapid and potent natriuretic response to intravenous injection of atrial myocardial extract in rats | Q34281894 | ||
| The Natural History of Congestive Heart Failure: The Framingham Study | Q34701680 | ||
| Cardiac fibrosis in mice lacking brain natriuretic peptide | Q35677878 | ||
| Natriuretic peptides and cyclic guanosine 3',5'-monophosphate in asymptomatic and symptomatic left ventricular dysfunction | Q36834363 | ||
| Biochemical diagnosis of ventricular dysfunction in elderly patients in general practice: observational study | Q38629847 | ||
| Symptomatic and asymptomatic left-ventricular systolic dysfunction in an urban population | Q39453635 | ||
| Incidence and aetiology of heart failure; a population-based study. | Q40816473 | ||
| Salt-resistant hypertension in mice lacking the guanylyl cyclase-A receptor for atrial natriuretic peptide | Q41273237 | ||
| The natriuretic-peptide family | Q41463095 | ||
| Atrial natriuretic peptide inhibits angiotensin-stimulated proximal tubular sodium and water reabsorption | Q43586570 | ||
| Can physicians always explain the results of clinical trials? A case study of amlodipine in heart failure | Q44554110 | ||
| Plasma brain natriuretic peptide level as a biochemical marker of morbidity and mortality in patients with asymptomatic or minimally symptomatic left ventricular dysfunction. Comparison with plasma angiotensin II and endothelin-1. | Q44835977 | ||
| The neurohormonal hypothesis: a theory to explain the mechanism of disease progression in heart failure | Q44860412 | ||
| Plasma levels of atrial natriuretic peptide during myocardial ischemia induced by percutaneous transluminal coronary angioplasty or dynamic exercise | Q45206177 | ||
| Is the secretion of atrial natriuretic peptide in man under neural control? | Q47326359 | ||
| Relation of plasma brain and atrial natriuretic peptides to left ventricular geometric patterns in essential hypertension | Q48099074 | ||
| A new natriuretic peptide in porcine brain | Q48100804 | ||
| Natriuretic peptides in patients with diastolic dysfunction due to idiopathic dilated cardiomyopathy | Q48112043 | ||
| Assessment of the stability of N-terminal pro-brain natriuretic peptide in vitro: implications for assessment of left ventricular dysfunction | Q48126258 | ||
| Relationship between natriuretic peptides and hemodynamics in patients with heart failure at rest and after ergometric exercise | Q48227095 | ||
| Sustained elevation of plasma brain natriuretic peptide levels associated with progressive ventricular remodelling after acute myocardial infarction | Q48299327 | ||
| Plasma B-type natriuretic peptide measurement in a multiphasic health screening program | Q48371543 | ||
| Prolonged stability of brain natriuretic peptide: importance for non-invasive assessment of cardiac function in clinical practice | Q48398779 | ||
| Effects of angiotensin-converting enzyme inhibitor on plasma B-type natriuretic peptide levels in patients with acute myocardial infarction | Q48488425 | ||
| Biochemical detection of left-ventricular systolic dysfunction | Q48562979 | ||
| Plasma brain natriuretic peptide levels increase in proportion to the extent of right ventricular dysfunction in pulmonary hypertension | Q48566482 | ||
| Immunoreactive amino-terminal pro-brain natriuretic peptide (NT-PROBNP): a new marker of cardiac impairment | Q48592649 | ||
| Augmented release of brain natriuretic peptide during reperfusion of the human heart after cardioplegic cardiac arrest | Q48708357 | ||
| Measurement of brain natriuretic peptide | Q48830891 | ||
| Diagnostic potential of cardiac natriuretic peptides in dialysis patients | Q48945446 | ||
| C-type natriuretic peptide (CNP): a new member of natriuretic peptide family identified in porcine brain | Q49017266 | ||
| Titration of vasodilator therapy in chronic heart failure according to plasma brain natriuretic peptide concentration: randomized comparison of the hemodynamic and neuroendocrine effects of tailored versus empirical therapy. | Q50515497 | ||
| Long-term infusion of atrial natriuretic peptide (ANP) improves renal blood flow and glomerular filtration rate in clinical acute renal failure. | Q51360063 | ||
| Plasma brain natriuretic peptide concentrations in healthy children from birth to adolescence: marked and rapid increase after birth | Q52206851 | ||
| Intravenous nesiritide, a natriuretic peptide, in the treatment of decompensated congestive heart failure. Nesiritide Study Group. | Q53907769 | ||
| Plasma concentration of brain natriuretic peptide as a biochemical marker for the evaluation of right ventricular overload and mortality in chronic respiratory disease. | Q54034466 | ||
| P433 | issue | 7 | |
| P921 | main subject | heart failure | Q181754 |
| P304 | page(s) | 571-588 | |
| P577 | publication date | 2001-07-01 | |
| P1433 | published in | Clinical Chemistry and Laboratory Medicine | Q5133754 |
| P1476 | title | The impact of cardiac natriuretic peptide determination on the diagnosis and management of heart failure | |
| P478 | volume | 39 |
| Q48725250 | Analytical evaluation of the Dade Behring Dimension RxL automated N-Terminal proBNP (NT-proBNP) method and comparison with the Roche Elecsys 2010. |
| Q47829708 | Analytical performance and diagnostic accuracy of a fully-automated electrochemiluminescent assay for the N-terminal fragment of the pro-peptide of brain natriuretic peptide in patients with cardiomyopathy: comparison with immunoradiometric assay me |
| Q33824641 | Aortic stiffness as a marker of cardiac function and myocardial strain in patients undergoing aortic valve replacement |
| Q35968889 | B-type natriuretic peptide and amino-terminal pro-B-type natriuretic peptide in pediatric patients with pulmonary arterial hypertension. |
| Q35566116 | B-type natriuretic peptide: physiologic role and assay characteristics. |
| Q79180914 | B-type ventricular peptide |
| Q35987052 | BNP Consensus Panel 2004: A clinical approach for the diagnostic, prognostic, screening, treatment monitoring, and therapeutic roles of natriuretic peptides in cardiovascular diseases |
| Q48398002 | BNP test utilization for CHF in community hospital practice |
| Q48285118 | Bedside B-Type natriuretic peptide in the emergency diagnosis of heart failure with reduced or preserved ejection fraction. Results from the Breathing Not Properly Multinational Study |
| Q37289418 | Biochemistry of B-type natriuretic peptide--where are we now? |
| Q33530170 | Biomarker for diagnosis of rejection after heart transplantation |
| Q38897414 | Brain natriuretic peptide and right heart dysfunction after heart transplantation. |
| Q35677306 | Can natriuretic peptides be used for the diagnosis of diastolic heart failure? |
| Q33773211 | Cardiac indexes, cardiac damage biomarkers and energy expenditure in professional cyclists during the Giro d'Italia 3-weeks stage race. |
| Q44983088 | Cardiac natriuretic hormones, neuro-hormones, thyroid hormones and cytokines in normal subjects and patients with heart failure. |
| Q43016274 | Cilostazol attenuates ventricular arrhythmia induction and improves defibrillation efficacy in swine. |
| Q36334557 | Clinical value of plasma B-type natriuretic peptide assay in pediatric pneumonia accompanied by heart failure |
| Q48304875 | Comparison between immunoradiometric and fluorimetric brain natriuretic peptide determination in patients with congestive heart failure |
| Q48364406 | Comparison of BNP and NT-proBNP assays in the approach to the emergency diagnosis of acute dyspnea. |
| Q35107199 | Congestive Heart Failure in Patients with Chronic Kidney Disease and on Dialysis |
| Q28601952 | Correlation between brain natriuretic peptide levels and the prognosis of patients with left ventricular diastolic dysfunction |
| Q48242668 | Direct comparison of transcardiac difference between brain natriuretic peptide (BNP) and N-terminal pro-BNP in patients with chronic heart failure |
| Q41188755 | Dynamic detection of N-terminal pro-B-type natriuretic peptide helps to predict the outcome of patients with major trauma |
| Q35132121 | Dynamics of the liver stiffness value using transient elastography during the perioperative period in patients with valvular heart disease |
| Q90114841 | Dysregulation of the Renin-Angiotensin System and Cardiometabolic Status in Mice Fed a Long-Term High-Fat Diet |
| Q36015470 | Effects of lesion complexity on baseline and postprocedural B-type natriuretic peptide levels in patients undergoing percutaneous coronary interventions. |
| Q47795710 | Effects of levosimendan in patients with left ventricular hypertrophy undergoing aortic valve replacement |
| Q48329269 | Evaluation of B-type natriuretic peptide for risk assessment in unstable angina/non-ST-elevation myocardial infarction: B-type natriuretic peptide and prognosis in TACTICS-TIMI 18. |
| Q36319305 | Exercise testing in adults after repair of aortic coarctation: evaluation of cardiopulmonary exercise capacity and B-type natriuretic protein levels. |
| Q37174127 | Exercise training improves cardiac function and attenuates arrhythmia in CPVT mice |
| Q49304954 | Falsely high B-type natriuretic peptide concentration in patients without heart failure attributed to AxSYM assay: case series of eight subjects |
| Q36939408 | Hyperthyroidism affects arterial stiffness, plasma NT-pro-B-type natriuretic peptide levels, and subendocardial perfusion in patients with Graves' disease |
| Q33820936 | Improved LFIAs for highly sensitive detection of BNP at point-of-care |
| Q44367892 | Improved neurohormonal markers of ventricular function after restoring sinus rhythm by the Maze procedure |
| Q48114522 | Independent effects of both right and left ventricular function on plasma brain natriuretic peptide |
| Q48278408 | Influence of gender on circulating cardiac natriuretic hormones in patients with heart failure |
| Q53027344 | Influence of sample matrix and storage on BNP measurement on the Bayer Advia Centaur. |
| Q48472680 | Intravenous diuretic and vasodilator therapy reduce plasma brain natriuretic peptide levels in acute exacerbation of chronic obstructive pulmonary disease |
| Q30445527 | Liver stiffness: a novel parameter for the diagnosis of liver disease |
| Q48566443 | Maximum longitudinal relaxation velocity of the left ventricle: its clinical value and relationship with NT-proBNP plasma levels in heart failure |
| Q37801768 | Mechanisms involved in increased plasma brain natriuretic peptide after heart transplantation |
| Q36236505 | Monitoring of patients with heart failure |
| Q45074456 | Multicenter analytical performance evaluation of the Elecsys proBNP assay |
| Q48946888 | N-Terminal-proBNP (NT-proBNP) as an indicator of cardiac dysfunction. A study in patients presenting with suspected cardiac disorders |
| Q37040910 | N-terminal pro B-type natriuretic peptide and the evaluation of cardiac dysfunction and severity of disease in cirrhotic patients |
| Q37093167 | N-terminal pro b-type natriuretic peptide (NT-pro-BNP) -based score can predict in-hospital mortality in patients with heart failure |
| Q37203628 | N-terminal pro-B-type natriuretic peptide as a marker of disease severity in patients with pericardial effusions |
| Q89898001 | N-terminal pro-B-type natriuretic peptide levels in children: comparison in cardiac and non-cardiac diseases |
| Q46881773 | N-terminal pro-brain natriuretic peptide (NT-proBNP) serum concentrations in apparently healthy Bosnian women. |
| Q49853451 | N-terminal-pro-B-type-natriuretic peptide associated with 2-year mortality from both cardiovascular and non-cardiovascular origins in prevalent chronic hemodialysis patients |
| Q33348965 | NT-pro-B-type natriuretic peptide in infants and children: reference values based on combined data from four studies |
| Q93159146 | NT-proBNP and Echocardiographic Parameters in Liver Cirrhosis - Correlations with Disease Severity |
| Q46678287 | NT-proBNP as a marker for persistent cardiac disease in children with history of dilated cardiomyopathy and myocarditis |
| Q64907287 | Natriuretic Peptides in Assessment of Ventricular Dysfunction. |
| Q48786001 | Nt-proBNP in haemodialysis patients: a preliminary study |
| Q37608515 | PAPP-A: a marker of plaque instability. Is it ready for prime time? |
| Q34976750 | Pathophysiological and clinical relevance of circulating levels of cardiac natriuretic hormones: are they merely markers of cardiac disease? |
| Q44237599 | Perinatal changes of circulating N-terminal pro B-type natriuretic peptide (NT-proBNP) in normal and intrauterine-growth-restricted pregnancies |
| Q48881592 | Pre-discharge B-type natriuretic peptide predicts early recurrence of decompensated heart failure in patients admitted to a general medical unit |
| Q40165610 | Prognostic Value of Serial N-Terminal Pro-Brain Natriuretic Peptide Testing in Patients With Acute Myocardial Infarction |
| Q33706264 | Prognostic value of brain natriuretic peptide in patients with heart failure and reserved left ventricular systolic function |
| Q48711307 | Reduced brain natriuretic peptide levels in class III obesity: the role of metabolic and cardiovascular factors. |
| Q35928009 | Relationship and prognostic importance of thyroid hormone and N-terminal pro-B-Type natriuretic peptide for patients after acute coronary syndromes: a longitudinal observational study |
| Q48591877 | Release pattern of N-terminal pro B-type natriuretic peptide (NT-proBNP) in acute coronary syndromes. |
| Q38089931 | Review on natriuretic peptides: where we are, where we are going |
| Q44241798 | Serial measurements of N-terminal pro-brain natriuretic peptide after acute ischemic stroke |
| Q48405207 | Serum levels of N-terminal pro-B-type natriuretic peptide are associated with allograft function in recipients of renal transplants |
| Q64927560 | Study of NT-proBNP and Hs-Troponin I biomarkers for early detection of children's heart function of proteinenergy malnutrition. |
| Q35206514 | The increasing impact of laboratory medicine on clinical cardiology |
| Q41777501 | The prognostic value of atrial and brain natriuretic peptides, troponin I and C-reactive protein in patients with sepsis |
| Q80769583 | The role of N terminal pro-brain natriuretic peptide in the evaluation of left ventricular diastolic dysfunction: correlation with echocardiographic indexes in hypertensive patients |
| Q37041902 | The time-course changes of NT-proBNP and tissue Doppler indices in patients undergoing mitral valve replacement |
| Q34190826 | Triiodothyronine and brain natriuretic peptide: similar long-term prognostic values for chronic heart failure |
| Q35750268 | Where, when and how much: regulation of myelin proteolipid protein gene expression |
| Q79882279 | [Biomarkers in cardiology--state of the art 2007] |
| Q80106721 | [NT-proBNP levels and hypertension. Their importance in the diagnosis of heart failure] |
| Q86268053 | [Perioperative care of patients with diastolic heart failure. Interface to anesthesia] |
| Q80399819 | [Urinary NT-proBNP level: relationship with ventricular function parameters in heart failure] |
Search more.